EUCAST Technical Note on Voriconazole and Aspergillus spp. (15th February 2013)

• Record Type: Journal Article
• Authors: Hope, W. W.; Cuenca‐Estrella, M.; Lass‐Flörl, C.; Arendrup, M. C.; Roilides, E.
• Is Part Of: Clinical microbiology and infection. Volume 19:Number 6(2013:Jun.)
• Page Start: E278
• Page End: E280
• Publication Date: 2013-02-15
• Subjects: Medical microbiology -- Periodicals; Diagnostic microbiology -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 616.01
• DOI: 10.1111/1469-0691.12148
• Languages: English
• ISSNs: 1198-743X

Abstract

<abstract abstract-type="main" id="clm12148-abs-0001"> <title>Abstract</title> <p>The European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST‐AFST) has determined breakpoints for voriconazole against <italic>Aspergillus</italic> spp. This Technical Note is based on the EUCAST rationale document for voriconazole (available on the EUCAST website: http://www.eucast.org). Voriconazole breakpoints are based on epidemiological cut‐off values, pharmacokinetic/pharmacodynamic data and clinical experience. Breakpoints will be reviewed regularly or when new data emerge.</p> </abstract>